Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Arsenal Capital Partners has raised $1.3 billion for its fourth investment fund. The New York City-based private equity firm invests in lower middle-market specialty industrial and health care companies. Current investments include the radiation cure resins maker IGM Resins and the drug development software firm Certara. Meanwhile, Sofinnova Partners has raised $650 million for its latest biotech investment fund. The fund plans to invest between $15 million and $35 million in 20 to 25 companies. Sofinovva says it has invested in 46 drug companies since 2007.
This article has been sent to the following recipient: